Related Experiment Video
Updated: May 18, 2026

Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults
Published on: December 1, 2023
Vitamin D levels and insulin resistance in children born with severe growth restriction
V I Giapros1, A S Challa, V L Cholevas
1Neonatal Intensive Care Unit, University Hospital of Ioannina, 45110 Ioannina, Greece. vgiapros@cc.uoi.gr
Insights
Children born small-for-gestational-age (SGA) have higher vitamin D levels and altered insulin resistance and beta-cell function at prepuberty. These vitamin D levels may influence beta-cell function in growth-restricted children.
Area of Science:
- Pediatric Endocrinology
- Nutritional Biochemistry
- Metabolic Health
Background:
- Small-for-gestational-age (SGA) birth is linked to long-term metabolic risks.
- Vitamin D status and its role in metabolic regulation are critical areas of research.
Purpose of the Study:
- To investigate serum 25(OH)D levels in prepubertal SGA versus appropriate-for-gestational-age (AGA) children.
- To correlate 25(OH)D levels with birth weight, insulin resistance (HOMA-IR), and beta-cell function (HOMA-β%).
Main Methods:
- Cross-sectional study of 65 nonobese children (5-7.5 years old).
- Measurement of serum 25(OH)D, PTH, glucose, and insulin.
- Calculation of HOMA-IR and HOMA-β% indices.
Main Results:
- SGA children exhibited significantly higher mean 25(OH)D levels (26.2 vs. 17.2 ng/ml).
- SGA group showed increased HOMA-IR and HOMA-β% compared to AGA.
- In SGA children, 25(OH)D correlated with HOMA-β%, not HOMA-IR.
- Total cohort: 25(OH)D and HOMA-IR negatively correlated with birth weight.
Conclusions:
- Prepubertal children born SGA have elevated, birth weight-dependent 25(OH)D levels.
- Increased 25(OH)D in SGA children may play a regulatory role in beta-cell function.
Abstract:
This study was designed to examine differences in serum 25(OH)D levels between small-for-gestational-age (SGA) and appropriate-for-gestational-age (AGA) prepubertal children in correlation with birth weight and indices of insulin resistance and β-cell function. Sixty-five nonobese children were examined at age 5-7.5 years; 27 born SGA and 38 matched AGA. Body weight, height, BMI, and waist circumference were recorded and fasting serum levels of glucose, insulin, 25(OH)D, and parathyroid hormone (PTH) were measured. The homeostasis model assessment for insulin resistance (HOMA-IR) and the β-cell function index (HOMA-β%) were estimated. The mean level of 25(OH)D was higher in the SGA group (26.2±10 vs. 17.2±7 ng/ml, p<0.01) but that of PTH was no different. The insulin resistance and β-cell function indices were higher in the SGA group: HOMA-IR 1.34±0.67 vs. 0.99±0.53, and HOMA-β% 135±56 vs. 97±60 in the SGA and AGA groups, respectively. In the SGA group, 25(OH)D was correlated with HOMA-β% but not with HOMA-IR or insulin. In multiple regression, in the total cohort 25(OH)D and HOMA-IR were independently negatively correlated with birth weight (β= - 0.31, β= - 0.36, p<0.05) respectively. In conclusion, at prepuberty severely in utero growth restricted children have increased birth weight dependent levels of 25(OH)D, which might exert a regulatory role on β-cell function.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes II: Pathophysiology
Type II Diabetes I: Introduction
